Cannabis stocks recovered ground Wednesday, as North American markets showed signs of life across the board.
The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, gained 1.7% to 83.2 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF rose 1.8% to C$7.21, while the OTCQX Cannabis index improved 2.7% to 334.1 points.
The company accepted an invitation to ring the opening bell at the Canadian Securities Exchange (CSE) on Friday in celebration of becoming the first CSE-listed company to dual list on a major US exchange.
FSD stock jumped nearly 12% to C$6.71 on the CSE and 16% to US$5.16 on the Nasdaq.
Canntab Therapeutics Limited (CSE:PILL) (OTCMKTS:CTABF) after earning a Health Canada Licence that allows them Processing & Sales for Medical Purposes.
Cannatb shares increased 7.4% to C$0.58.
There was no runaway laggard on Wednesday, but a handful of cannabis stocks were worse for the wear in the midweek.
GW Pharmaceuticals plc (NASDAQ:GWPH), a cannabinoid pharmaceutical company, dipped 1.7% to US$100.20.
Contact Andrew Kessel at email@example.com
Follow him on Twitter @andrew_kessel